Biocon, Handok ink pact for commercialization of chronic weight management Liraglutide in South Korea
Bengaluru: A global biopharmaceutical company, Biocon Limited, has announced the signing of an exclusive licensing and supply agreement with Handok, a specialty pharmaceutical company in South Korea, for the commercialization of its Synthetic Liraglutide, …